Clinical Trials Directory

Trials / Completed

CompletedNCT00232219

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Melbourne Health · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion. Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion. Cardioversion involves resetting the heart back to normal with the use of electric current. There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion. Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

Conditions

Interventions

TypeNameDescription
DRUGFish oil

Timeline

Start date
2003-01-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2005-10-04
Last updated
2015-05-05

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00232219. Inclusion in this directory is not an endorsement.